ALDX EPS Estimates
Aldeyra Therapeutics, Inc.
$0.79
-$0.11(-12.16%)
28
Overall
50
Value
18
Tech
18
Quality
Market Cap
$47.68M
Volume
1.58M
52W Range
$0.86 - $5.93
Target Price
$6.25
ALDX EPS estimates: the consensus estimate for Aldeyra Therapeutics, Inc.'s current fiscal year is -$0.39 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ALDX EPS Estimates
- EPS estimate, current quarter
- $-0.11
- EPS estimate, next quarter
- $-0.13
- EPS estimate, current year
- $-0.39
- EPS estimate, next year
- $-0.16
- EPS growth, 3-year
- +19.16%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.56 |
| 2024 | $-0.94 |
| 2023 | $-0.64 |
| 2022 | $-1.06 |
| 2021 | $-1.07 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALDX | $0.79 | -12.2% | 1.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aldeyra Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW